Ribonucleic acid (RNA) is one of life's most versatile molecules, with roles going far beyond being a messenger of genetic ...

Cells contain a blueprint in the form of DNA that dictates what they can make. This blueprint is converted into a message ...

What if the brain's response to stress could be read not in fleeting neurotransmitter bursts, but in the quieting of genes ...

Researchers at the University Hospital Bonn (UKB) and the University of Bonn have discovered how a small, naturally occurring ...

The decades-long quest to harness the power of messenger RNA to enhance cancer treatment has focused primarily on its value ...

Earlier in the week, Novartis said it entered into an agreement with Avidity Biosciences, Inc. (NASDAQ:RNA) to acquire the ...

Fintel reports that on October 27, 2025, Citigroup downgraded their outlook for Avidity Biosciences (NasdaqGM:RNA) from Buy ...

Fintel reports that on October 27, 2025, Needham downgraded their outlook for Avidity Biosciences (NasdaqGM:RNA) from Buy to ...

Everyone knows that the fall brings flu season, replete with aches, pains and a new version of the vaccine. But why is cold ...

The Packard Center and ALS United will fund a preclinical study investigating how abnormal TDP-43 protein contributes to ALS.

Cells contain a blueprint in the form of DNA that dictates what they can make.This blueprint is converted into a message, or mRNA, which is then ...

Avidity Biosciences (RNA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.